Condition: Gallbladder Cancer Unresectable
Intervention: Radiation: chemoradiation
Sponsors: Sanjay Gandhi Postgraduate Institute of Medical Sciences; American Society of Clinical Oncology
Recruiting
Feeds
26207 items (26207 unread) in 74 feeds
Acinar Cell Carcinoma
(165 unread)
Acinic Cell Carcinoma
(99 unread)
Adenoid Cystic Carcinoma
(516 unread)
Adrenal Gland Cancer
(2081 unread)
Ampulla Of Vater
(453 unread)
Anal Cancer
(2039 unread)
Angiosarcoma
(571 unread)
Appendix Cancer
(508 unread)
Bile Duct Cancer
(3039 unread)
Brain and CNS
(3777 unread)
Carcinoid
(806 unread)
Endocrine/Neuroendocrine
(3788 unread)
Gall Bladder Cancer
(1307 unread)
Hemangioendothelioma
(614 unread)
Hepatoblastoma
(445 unread)
Pancreas
(251 unread)
Phyllodes
(128 unread)
PMP and Mucinous Tumors
(319 unread)
Rhabdomyosarcoma
(965 unread)
Sarcoma
(4336 unread)
Trials - Gall Bladder Cancer (38 unread)
-
A Randomised Study of Consolidation CTRT Versus Observation After First Line Chemotherapy in Advanced Gallbladder Cancer
Posted: August 9th, 2022, 2:00pm GMT
-
The PLATON Network
Posted: August 5th, 2022, 2:00pm GMT
Conditions: Hepatocellular Cancer; Cholangiocarcinoma; Gallbladder Cancer; Pancreatic Cancer; Oesophageal Cancer; Stomach Cancer
Intervention:
Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Recruiting -
Evaluating Novel Therapies in ctDNA Positive GI Cancers
Posted: August 1st, 2022, 2:00pm GMT
Conditions: Colon Adenocarcinoma; Rectal Adenocarcinoma; Gastric Adenocarcinoma; Pancreatic Adenocarcinoma; Hepatocellular Carcinoma; Adenocarcinoma of Biliary Tract; Gallbladder Adenocarcinoma
Interventions: Drug: Atezolizumab; Drug: Bevacizumab
Sponsors: Georgetown University; Genentech, Inc.; Natera, Inc.
Not yet recruiting -
Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED)
Posted: July 11th, 2022, 2:00pm GMT
Conditions: Pancreatic Cancer; Hepatocellular Cancer; Biliary Tract Cancer; Cholangiocarcinoma
Interventions: Biological: Durvalumab; Drug: Gemcitabine; Drug: Nab paclitaxel; Biological: Tremelimumab; Drug: Propranolol; Drug: Cisplatin
Sponsor: AHS Cancer Control Alberta
Not yet recruiting -
Safety and Feasibility of HIPEC for High-Risk Gallbladder Adenocarcinoma
Posted: June 24th, 2022, 2:00pm GMT
Condition: Gallbladder Adenocarcinoma
Intervention: Drug: HIPEC
Sponsor: West Virginia University
Not yet recruiting -
NGS in Gallbladder Cancer and Response to Treatment
Posted: June 3rd, 2022, 2:00pm GMT
Condition: Gallbladder Cancer
Intervention: Diagnostic Test: Next generation sequencing
Sponsor: Banaras Hindu University
Recruiting -
RADIO FREQUENCY ABLATION IN UNRESECTABLE MALIGNANT BILIARY OBSTRUCTION
Posted: April 11th, 2022, 2:00pm GMT
Conditions: Bile Duct Neoplasms; Gall Bladder Carcinoma
Intervention: Device: Radio frequency ablation
Sponsor: Asian Institute of Gastroenterology, India
Recruiting -
Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases
Posted: March 17th, 2022, 2:00pm GMT
Conditions: Distal Bile Duct Adenocarcinoma; Gallbladder Carcinoma; Intrahepatic Cholangiocarcinoma; Metastatic Malignant Neoplasm in the Peritoneum; Stage IV Distal Bile Duct Cancer AJCC v8; Stage IV Intrahepatic Bile Duct Cancer AJCC v8; Stage IV Intrahepatic Cholangiocarcinoma AJCC v8; Stage IVB Gallbladder Cancer AJCC v8
Interventions: Drug: Cisplatin; Drug: Gemcitabine; Drug: Nab-paclitaxel; Other: Quality-of-Life Assessment; Other: Questionnaire Administration
Sponsors: City of Hope Medical Center; National Cancer Institute (NCI)
Recruiting -
FEASIBILITY OF EUS-GUIDED GALLBLADDER DRAINAGE WITH A NEW-TYPE OF ELECTROCAUTETERY LAMS IN THE TREATMENT OF MALIGNANT DISTAL MALIGNANT BILIARY OBSTRUCTION
Posted: March 9th, 2022, 3:00pm GMT
Condition: Distal Malignant Biliary Obstruction
Intervention: Procedure: endoscopic biliary drainage
Sponsor: Istituto Clinico Humanitas Mater Domini
Recruiting -
Immunotherapy With Durva and Treme With or Without Capecitabine in Adjuvant Treatment for Biliary Tract Cancer
Posted: February 14th, 2022, 3:00pm GMT
Conditions: Biliary Tract Cancer (CCA); Intrahepatic Cholangiocarcinoma; Hilar Cholangiocarcinoma; Distal Cholangiocarcinoma; Gall Bladder Carcinoma
Interventions: Drug: Durvalumab; Drug: Tremelimumab; Drug: Capecitabine
Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Recruiting -
A Prospective Study of UCAD for Diagnosing Benign or Malignant Biliary Obstruction and Follow-up
Posted: February 14th, 2022, 3:00pm GMT
Conditions: Biliary Tract Neoplasms; Pancreatic Carcinoma; Gallbladder Cancer; Pancreatic Head Carcinoma
Intervention: Diagnostic Test: The level of CIN
Sponsors: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine; Shanghai Zhongshan Hospital; Ruijin Hospital; Changhai Hospital; Shanghai Changzheng Hospital; Eastern Hepatobiliary Surgery Hospital; First Affiliated Hospital Xi'an Jiaotong University; Jiangsu Provincial People's Hospital; Third Affiliated Hospital, Sun Yat-Sen University; First Affiliated Hospital of Zhejiang University; The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School; Second Hospital of Jilin University; West China Hospital; Southwest Hospital, China; Affiliated Hospital of North Sichuan Medical College; Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Recruiting -
A Study of SGN-B7H4V in Advanced Solid Tumors
Posted: January 18th, 2022, 3:00pm GMT
Conditions: Ovarian Neoplasms; Peritoneal Neoplasms; Fallopian Tube Neoplasms; Triple Negative Breast Neoplasms; HER2 Negative Breast Neoplasms; Hormone Receptor Positive Breast Neoplasms; Endometrial Neoplasms; Carcinoma, Non-Small-Cell Lung; Cholangiocarcinoma; Gallbladder Carcinoma
Intervention: Drug: SGN-B7H4V
Sponsor: Seagen Inc.
Recruiting -
A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid Tumors
Posted: October 12th, 2021, 2:00pm GMT
Conditions: Solid Tumor, Adult; Pancreatic Ductal; Adenocarcinoma; Ovarian Serous Adenocarcinoma; Biliary Cancer Metastatic; Ovarian Serous Cystadenocarcinoma
Intervention: Drug: ZB131
Sponsor: ZielBio, Inc.
Recruiting -
Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
Posted: August 11th, 2021, 2:00pm GMT
Conditions: Bile Duct Cancer; Gall Bladder Cancer; Breast Cancer; Neuroendocrine Tumors; Ovarian Cancer; Pancreatic Adenocarcinoma; Soft Tissue Sarcoma; Vulvar Cancer; Prostate Cancer
Interventions: Drug: Atezolizumab; Drug: Tivozanib
Sponsors: University of Florida; Genentech, Inc.; Aveo Oncology Pharmaceuticals
Recruiting -
Combination Immunotherapy in Rare Cancers Under InvesTigation
Posted: July 21st, 2021, 2:00pm GMT
Conditions: Advanced Biliary Tract Cancer; Neuroendocrine Tumors; Female Reproductive System Neoplasm; MSI-H Solid Malignant Tumor
Interventions: Drug: Ipilimumab; Drug: Nivolumab
Sponsors: Olivia Newton-John Cancer Research Institute; Bristol-Myers Squibb
Recruiting -
The ID- RFA Trial: A Trial of Intraductal Radio-frequency Ablation (ID-RFA) Plus Biliary Stenting Versus Biliary Stenting Alone for the Treatment of Malignant Biliary Obstruction.
Posted: June 28th, 2021, 2:00pm GMT
Condition: Malignant Biliary Obstruction
Interventions: Procedure: Intraductal Radio-Frequency Ablation; Device: Biliary Stent Placement
Sponsors: University Hospitals Dorset NHS Foundation Trust; Aquilant Services; The Christie NHS Foundation Trust
Not yet recruiting -
Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels
Posted: June 18th, 2021, 2:00pm GMT
Conditions: Metastatic Cancer; Foregut Carcinoid Tumor; Gastric Adenocarcinoma; Gallbladder Adenocarcinoma; Liver Cancer; GI Cancer; GI Carcinoma; Lung Cancer
Interventions: Drug: Standard of Care Chemotherapy; Procedure: Video-Assisted Thoracic Surgery (VATS); Procedure: Lobectomy; Radiation: Consolidative Radiation; Radiation: Ablation Treatment; Procedure: Resection or Excision; Procedure: Peritonectomy; Other: Transarterial Radioembolization
Sponsor: University of Chicago
Not yet recruiting -
A Study to Assess RXC004 Efficacy in Advanced Solid Tumours After Progression on Standard of Care (SoC) Therapy (PORCUPINE2)
Posted: June 1st, 2021, 2:00pm GMT
Condition: Advanced Solid Tumours
Interventions: Drug: RXC004; Biological: Denosumab
Sponsor: Redx Pharma Plc
Recruiting -
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
Posted: June 1st, 2021, 2:00pm GMT
Conditions: Cancer Pain; Visceral Pain; Gastrointestinal Neoplasms; Cancer of Gastrointestinal Tract; Small Intestine Cancer; Pancreas Cancer; Liver Cancer; Colon Cancer; Biliary Tract Cancer; Stomach Cancer; Rectum Cancer; Peritoneal Cancer; Gastrointestinal Cancer Metastatic; Gastrointestinal Cancers - Anus; Gastrointestinal Cancers - Stomach; Gastrointestinal Cancers - Colorectal; Gastrointestinal Cancers - Small Intestine; Small Intestine Cancer Stage III; Small Intestine Cancer Stage IV; Small Intestine Cancer, Recurrent; Pancreas Cancer, Stage III; Pancreas Cancer, Stage IV; Pancreas Cancer, Metastatic; Pancreas Cancer, Recurrent; Liver Cancer Stage IIIa; Liver Cancer Stage IIIb; Liver Cancer Stage IIIc; Liver Cancer Stage IV; Colon Cancer Stage III; Colon Cancer Stage IV; Stomach Cancer Stage III; Stomach Cancer Stage IV; Stomach Cancer Recurrent; Rectum Cancer, Recurrent; Gastrointestinal Cancers - Liver; Anal Cancer; Anal Cancer Stage III; Anal Cancer Stage IV; Anal Cancer Recurrent; Anal Cancer Metastatic; Anal Cancer, Stage IIIA; Anal Cancer, Stage IIIB; Appendix Cancer; Ampullary Cancer; Bile Duct Cancer; Bile Duct Cancer Stage III; Bile Duct Cancer Stage IV; Bile Duct Cancer Stage IVA; Bile Duct Cancer Stage IVB; Bile Duct Cancer Recurrent; Carcinoid Tumor; Carcinoid Tumor of Pancreas; Carcinoid Tumor of Large Intestine; Carcinoid Tumor of GI System; Carcinoid Tumor of Colon; Carcinoid Tumor of Liver; Carcinoid Tumor of Cecum; Carcinoid Tumor of Ileum; Carcinoid Tumor of Rectum; Carcinoid Tumor of the Small Bowel; Carcinoid Tumor of the Stomach; Large Intestine Cancer; Esophagus Cancer; Esophagus Cancer, Stage III; Esophagus Cancer, Stage IV; Esophagus Cancer, Recurrent; Gallbladder Cancer; Gallbladder Cancer Stage III; Gallbladder Cancer Stage IV; Gastric (Stomach) Cancer; Neuroendocrine Tumor; Peritoneum Cancer; Rectal Cancer; Esophagus Cancer, Stage I; Esophagus Cancer, Stage II; Gallbladder Cancer Stage I; Gallbladder Cancer Stage II; Bile Duct Cancer Stage I; Bile Duct Cancer Stage II
Intervention: Device: PICO G2 4k
Sponsors: Cedars-Sinai Medical Center; National Cancer Institute (NCI)
Recruiting -
New Prospective Expanded German Registry of Incidental Gallbladder Carcinoma (PERSUASION)- a Permanent Platform Including All Kind of Biliary Tract Cancers (BTC)
Posted: May 21st, 2021, 2:00pm GMT
Conditions: Biliary Tract Cancer; Neoadjuvant, Adjuvant and 1st Line
Intervention:
Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Recruiting -
Study of TT-00420 Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors
Posted: February 8th, 2021, 3:00pm GMT
Conditions: Advanced Solid Tumor; Cholangiocarcinoma; HER2-negative Breast Cancer; Triple Negative Breast Cancer; Bladder Cancer; Small-cell Lung Cancer; Prostate Cancer; Thyroid Cancer; Sarcoma; Gastric Cancer; Gallbladder Cancer
Interventions: Drug: TT-00420; Combination Product: Nab-Paclitaxel
Sponsor: TransThera Sciences (Nanjing), Inc.
Recruiting -
A Dual Channel Supraglottic Airway Device (LMA Gastro) for Oxygenation in Patients Undergoing ERCP
Posted: February 5th, 2021, 3:00pm GMT
Conditions: Bile Duct Carcinoma; Gallbladder Carcinoma; Pancreatic Ductal Adenocarcinoma
Intervention: Procedure: Endoscopic Retrograde Cholangiopancreatography
Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI)
Recruiting -
Prophylactic Cholecystectomy in Midgut NETs Patients Who Require Primary Tumor Surgery.
Posted: February 3rd, 2021, 3:00pm GMT
Conditions: Midgut Carcinoid Tumor; Biliary Stones
Interventions: Procedure: Primary tumor surgery; Procedure: Primary tumor surgery (bowel resection) combined with prophylactic cholecystectomy
Sponsor: Hospital Universitari de Bellvitge
Recruiting -
18F-DOPA II - PET Imaging Optimization
Posted: January 13th, 2021, 3:00pm GMT
Conditions: Congenital Hyperinsulinism; Neuroblastoma; Parkinson Disease; Lewy Body Disease; Neuroendocrine Tumors; Brain Tumor
Interventions: Drug: 18F-DOPA; Drug: Furosemide Injection
Sponsor: University of Alberta
Recruiting -
Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract Tumors
Posted: December 24th, 2020, 3:00pm GMT
Conditions: Solid Tumor; Gastric Cancer; Gastroesophageal Junction Adenocarcinoma; Esophageal Adenocarcinoma; Pancreatic Cancer; Biliary Tract Cancer; Cholangiocarcinoma; Metastatic Cancer
Interventions: Biological: BNT141; Drug: Nab-paclitaxel; Drug: Gemcitabine
Sponsor: BioNTech SE
Recruiting -
Feasibility Study of Multi-Platform Profiling of Resected Biliary Tract Cancer
Posted: September 23rd, 2020, 2:00pm GMT
Conditions: Biliary Tract Cancer; Cholangiocarcinoma; Gallbladder Cancer; Intrahepatic Cholangiocarcinoma; Perihilar Cholangiocarcinoma; Extrahepatic Cholangiocarcinoma; Hilar Cholangiocarcinoma; Distal Bile Duct Cancer
Intervention: Diagnostic Test: Multi-Platform Profiling with Organoid Drug Sensitivity Screening and ctDNA Monitoring
Sponsors: University of Washington; Natera, Inc.; SEngine Precision Medicine, Inc.
Recruiting -
A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of TST001 in Advanced or Metastatic Solid Tumors
Posted: July 31st, 2020, 2:00pm GMT
Condition: Advanced Cancer
Intervention: Biological: TST001 injection
Sponsors: Mabspace Biosciences (Suzhou) Co., Ltd.; Beijing Cancer Hospital; First Affiliated Hospital of Zhejiang University; Fudan University; Henan Cancer Hospital; Second Affiliated Hospital, School of Medicine, Zhejiang University; Tianjin Medical University Cancer Institute and Hospital; First Affiliated Hospital Bengbu Medical College; The First People's Hospital of Jingzhou; Sixth Affiliated Hospital, Sun Yat-sen University; Beijing Friendship Hospital; Tianjin Medical University General Hospital; Hainan People's Hospital; Hubei Cancer Hospital; Jilin Provincial Tumor Hospital; Jinan Central Hospital; Liaoning Cancer Hospital & Institute; Sichuan Cancer Hospital and Research Institute; The Affiliated Hospital of Qingdao University; The First Affiliated Hospital of Zhengzhou University; The First Hospital of Jilin University; Second Affiliated Hospital of Nanchang University; Second Affiliated Hospital of Soochow University; West China Hospital; Fujian Cancer Hospital; Zhejiang Cancer Hospital; First Affiliated Hospital of Chongqing Medical University; Xuzhou Central Hospital; Suzhou Municipal Hospital; First Hospital of China Medical University; Fujian Medical University Union Hospital; Bristol-Myers Squibb
Recruiting -
PLATON - Platform for Analyzing Targetable Tumor Mutations (Pilot-study)
Posted: July 23rd, 2020, 2:00pm GMT
Conditions: Hepatocellular Cancer; Cholangiocarcinoma; Gallbladder Cancer; Pancreatic Cancer; Oesophageal Cancer; Stomach Cancer
Intervention: Diagnostic Test: FoundationOne®CDx and FoundationOne®Liquid
Sponsors: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest; Roche Pharma AG
Recruiting -
A Study of ZW25 (Zanidatamab) in Subjects With Advanced or Metastatic HER2-Amplified Biliary Tract Cancers
Posted: July 10th, 2020, 2:00pm GMT
Condition: HER2-amplified Biliary Tract Cancers
Interventions: Drug: ZW25 (Zanidatamab); Diagnostic Test: In situ hybridization (ISH)-based companion diagnostic assay; Diagnostic Test: Immunohistochemistry (IHC)-based companion diagnostic assay
Sponsors: Zymeworks Inc.; BeiGene, Ltd.
Recruiting -
Hepatobiliary Tumors Tissue Samples Acquisition
Posted: June 24th, 2020, 2:00pm GMT
Conditions: Hepatocellular Carcinoma; Cholangiocarcinoma; Gallbladder Cancer; Biliary Tract Cancer; Liver Cancer; Precancerous Condition; Benign Hepatobiliary Disease; Healthy, no Evidence of Disease
Interventions: Other: Gene expression analysis; Other: Genomic analysis; Other: Protein expression analysis; Other: Proteomic profiling; Other: Polymerase chain reaction; Other: Mass spectrometry; Other: Immunohistochemistry; Other: Metabolomics profiling; Other: Methylation and epigenetic analysis; Other: Liquid biopsy analysis; Other: Laboratory biomarker analysis
Sponsors: Peking Union Medical College Hospital; OrigiMed; GeneCast Biotechnology Co., Ltd.; YuceBio Technology Co., Ltd.
Recruiting -
Comparing the Current Hydration Regimen for the ABC02 Chemotherapy Regimen Versus a Shorter Hydration
Posted: April 27th, 2020, 2:00pm GMT
Condition: Gallbladder Cancer
Interventions: Combination Product: Shortened hydration time and dispensary of Akynzeo; Combination Product: Standard of care
Sponsors: Imperial College Healthcare NHS Trust; Chugai Pharma UK Limited
Recruiting -
The Incidence of Gallstones After Gastric Cancer Surgery
Posted: January 31st, 2020, 3:00pm GMT
Conditions: Gallstones; Gastric Cancer
Intervention: Procedure: Resection
Sponsor: Hepatopancreatobiliary Surgery Institute of Gansu Province
Recruiting -
Gemcitabine and Cisplatin With or Without CPI-613 as First Line Therapy for Patients With Advanced Unresectable Biliary Tract Cancer (BilT-04)
Posted: December 18th, 2019, 3:00pm GMT
Condition: Biliary Tract Cancer
Interventions: Drug: CPI 613; Drug: Gemcitabine; Drug: Cisplatin
Sponsor: University of Michigan Rogel Cancer Center
Recruiting -
Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab
Posted: November 15th, 2019, 3:00pm GMT
Conditions: Advanced Colorectal Carcinoma; Metastatic Colorectal Carcinoma; Stage IV Colorectal Cancer AJCC v8; Stage IVA Colorectal Cancer AJCC v8; Stage IVB Colorectal Cancer AJCC v8; Stage IVC Colorectal Cancer AJCC v8; Stage II Colon Cancer; Stage II Rectal Cancer; Stage III Colon Cancer; Stage III Rectal Cancer; Esophageal Cancer; Pancreatic Cancer; Bile Duct Cancer; Gastric Cancer; Gall Bladder Cancer; Small Bowel Adenocarcinoma
Interventions: Biological: Bevacizumab; Drug: Dasatinib; Drug: Fluorouracil; Drug: Leucovorin; Drug: Leucovorin Calcium; Drug: Oxaliplatin; Other: Quality-of-Life Assessment
Sponsor: Anne Noonan
Recruiting -
Effect of Simvastatin on the Prognosis of Primary Primary Sclerosing Cholangitis (PSC)
Posted: October 21st, 2019, 2:00pm GMT
Condition: Primary Sclerosing Cholangitis
Interventions: Drug: Simvastatin 40mg; Drug: Placebo oral tablet
Sponsor: Annika Bergquist
Recruiting -
A Study to Evaluate Safety, Tolerability and Preliminary Efficacy of FP-1305 in Cancer Patients
Posted: November 7th, 2018, 3:00pm GMT
Condition: Cancer
Intervention: Biological: FP-1305 (bexmarilimab)
Sponsor: Faron Pharmaceuticals Ltd
Recruiting -
Perioperative Therapy Preoperative Chemotherapy Versus Chemoradiotherapy in Locally Advanced Gall Bladder Cancers
Posted: August 16th, 2016, 2:00pm GMT
Condition: Gall Bladder Cancers
Interventions: Drug: Gemcitabine; Drug: Cisplatin; Radiation: Chemoradiation; Procedure: PETCECT; Procedure: Laparoscopy
Sponsor: Tata Memorial Hospital
Recruiting -
Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Biliary Tract Cancer
Posted: June 23rd, 2014, 2:00pm GMT
Conditions: Cholangiocarcinoma; Gall Bladder Carcinoma
Interventions: Drug: Gemcitabine; Drug: Cisplatin; Drug: Capecitabine
Sponsors: Universitätsklinikum Hamburg-Eppendorf; Deutsche Krebshilfe e.V., Bonn (Germany); Cancer Research UK; Australasian Gastro-Intestinal Trials Group; Dutch Cancer Society
Recruiting